Sheng joins Genentech from the Massachusetts Institute of Technology,where he was Menicon Professor of Neuroscience at the Power Institute for Learning and Memory and RIKEN-MIT Neuroscience Research Center in the departments of brain and cognitive science and biology.
Harold Ingalls, Morgan Sheng
Sep 12, 2008
Aruna Biomedical announced this week that it has appointed Harold "Bud" Ingalls to its board of directors.
Prior to his current role as CFO of Premier Exhibitions, Ingalls served as vice president and chief financial officer at CardioMEMS. From 2001 to 2006, Ingalls served as vice president of finance and chief financial officer of Serologicals. Prior to Serologicals, Ingalls was employed as president and chief financial officer of LaRoche Industries.
Genentech has appointed Morgan Sheng as vice president of neuroscience, effective Sept. 15, the company said this week. In this newly created position, Sheng will be responsible for directing neurobiology drug discovery efforts at Genentech and will oversee the department of neurobiology.